Anaesthesiological Routine Care for Thrombectomy in Cerebral Ischaemia
Launched by EUROPEAN SOCIETY OF ANAESTHESIOLOGY · Aug 18, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care provided by anaesthesiologists during a specific procedure called endovascular thrombectomy, which is used to treat serious strokes caused by blocked blood vessels in the brain. The researchers want to understand how different anaesthesia techniques and management strategies can affect the outcomes for patients undergoing this treatment. They will be looking at various factors to see which ones are linked to better or worse recovery after the procedure.
To participate in this study, patients must be between 65 and older and require anaesthesia for their endovascular stroke treatment. Those who have strokes that begin while they are already in the hospital, are involved in other studies about anaesthesia protocols, or are younger than 18 years will not be eligible. If you join the trial, you can expect to receive standard care during your treatment while helping researchers gather important information that could improve future stroke care. This study is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Endovascular stroke treatment involving anaesthesia care
- Exclusion Criteria:
- • In-hospital onset of stroke
- • Inclusion in an interventional study concerning the anaesthesia protocol
- • Age under 18 years
About European Society Of Anaesthesiology
The European Society of Anaesthesiology (ESA) is a leading professional organization dedicated to advancing the field of anaesthesiology through research, education, and collaborative practice. Committed to enhancing patient safety and outcomes, the ESA sponsors clinical trials that focus on innovative anaesthetic techniques, pain management, and perioperative care. By fostering a network of professionals and promoting evidence-based practices, the ESA plays a crucial role in shaping the future of anaesthesia and improving the quality of healthcare across Europe and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
München, , Germany
Patients applied
Trial Officials
Andreas Ranft, Dr.
Study Chair
Senior Physician-München, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials